Lucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration.

Source:http://linkedlifedata.com/resource/pubmed/id/20957143

Download in:

View as

General Info

PMID
20957143